Health
Sirnaomics Announces a Partnership with Gore Range Capital for Establishment of a JV, Sagesse Bio, to Advance Its RNAi Therapeutics into Aesthetic Medicine
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, Aug. 1, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, to...
Prestige Biopharma's Herceptin Biosimilar Tuznue® Receives Positive CHMP Opinion from the EMA
* Following approval by the European Commission, Prestige Biopharma's Herceptin biosimilar Tuznue® would become the first biosimilar from a Singaporean company to be authorized in the European Union. SINGAPORE, Aug. 1, 2024 /PRNewswire/ -- Prestige Biopharma, a pioneer in biopharmaceuticals, a...
Angel Yeast Driving Green Transformation Though Technological Innovation
SHANGHAI, July 31, 2024 /PRNewswire/ -- Angel Yeast (en.angelyeast.com
PROCESSED RED MEAT RAISES THE RISK OF DEMENTIA; SWAPPING IT FOR NUTS AND BEANS MAY LOWER RISK
Four-decade study of more than 130,000 people measured the risk of your morning bacon or ballgame hot dog Key Takeaways * Eating about two servings per week of processed red meat raises the risk of dementia by 14% compared to those who eat less than approximately three servings a month. * S...
Kexing Biopharm's Albumin-bound Paclitaxel Granted EU Market Approval
SHENZHEN, China, July 31, 2024 /PRNewswire/ -- On July 28 2024, Kexing Biopharm announced European Commission approval of Apexelsin®, the generic drug to Bristol Myers Squibb's and Celgene's Abraxane®(Nab-paclitaxel). Apexelsin® is developed by WhiteOak Pharmaceutical B.V. and Kexing Biopharm is ...
Australian tech leading new digital biosecurity infrastructure
SYDNEY, July 31, 2024 /PRNewswire/ -- With highly pathogenic avian influenza expected to hit our shores in as little as six weeks, a real time biosecurity threat management system will be critical to response and recovery, according to Adrian Turner, co-founder of Australian tech startup ExoFlare....
Connext Successfully Administers First Dose of CNT201 for Dupuytren's Contracture
World's First Genetically Recombinant Collagenase Therapeutics (CNT201) Begins Clinical Trials inAustralia SEOUL, South Korea, July 30, 2024 /PRNewswire/ -- Connext has announced the successful first administration of CNT201, its therapeutic treatment for Dupuytren's contracture, in patients. D...
Sengenics Corporation Unveils i-Ome® Cancer: A Breakthrough in Cancer Precision Medicine
Revolutionizing Biomarker Discovery with a High-Throughput Immunoproteomic Platform BOSTON, July 30, 2024 /PRNewswire/ -- Sengenics Corporation LLC is proud to announce the launch of i-Ome Cancer, a cutting-edge research tool designed to transform cancer biomarker discovery using just a drop of ...
GLP-1 DRUG LIRAGLUTIDE MAY PROTECT AGAINST DEMENTIA
Key Takeaways * A GLP-1 agonist — the class of drugs shown to help with diabetes and weight loss and reduce the risk of heart disease — also may protect the brain. * In a Phase 2b trial, liraglutide appears to reduce shrinking in the parts of the brain that control memory, learning, language ...
Sedafiat Sdn. Bhd. Claims Victory with Corporate Excellence Award at the Asia Pacific Enterprise Awards 2024 Malaysia
SINGAPORE, July 30, 2024 /PRNewswire/ -- Sedafiat Sdn. Bhd. was honored with the prestigious Corporate Excellence Award at the Asia Pacific Enterprise Awards (APEA) 2024 Malaysia. Organized annually across 16 markets by Enterprise Asia, APEA serves asAsia's premier award networking platform. A ni...
Clarivate Introduces New OFF-X ™ Platform for Preclinical and Clinical Safety Intelligence
Empowering biopharma with enhanced safety insights to anticipate risks and unlock new competitive advantages LONDON, July 30, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the launch of the newOFF-X™ platform. The enhance...
AS Watson Group Triumphs with 36 Stevie® Awards in the 11th annual Asia-Pacific Stevie Awards 2024
HONG KONG, July 30, 2024 /PRNewswire/ -- AS Watson Group, the world's largest international health and beauty retailer, has achieved an impressive 36 Stevie® Awards and been named the Overall Winner and received the Grand Stevie Award in the 11th annual Asia-Pacific Stevie Awards® 2024. These acc...
Baxter's Helion System Launches in Thailand, Bringing Comprehensive Simplicity to ORs
BANGKOK, July 30, 2024 /PRNewswire/ -- Baxter International Inc
NCCN and Medlive Renew Collaboration to Enhance Cancer Care in China
United States-based National Comprehensive Cancer Network strengthens relationship with Chinese medical platform Medlive to broaden access to eminent oncology guidelines inChina PLYMOUTH MEETING, Pa., July 30, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®), an alliance o...
NEURIM PHARMACEUTICALS RECEIVES POSITIVE CHMP OPINION ON SLENYTO® (PEDIATRIC PROLONGED-RELEASE MELATONIN) FOR THE TREATMENT OF INSOMNIA IN CHILDREN WITH NEUROGENETIC DISORDERS (NGDs)
TEL-AVIV, Israel, July 30, 2024 /PRNewswire/ -- Neurim Pharmaceuticals
SK Telecom Expands 'X Caliber' Veterinary Diagnosis Assistant to Three Major Southeast Asian Markets
- SK Telecom signs agreements in Malaysia, Thailand and Vietnam to supply 'X Caliber', its AI-based veterinary diagnosis service, as demand for pet care grows SEOUL, South Korea, July 30, 2024 /PRNewswire/ -- SK Telecom (NYSE: SKM, "SKT") announced today that it has signed agreements to supply i...
CSafe launches reusable Silverpod pallet shipper to help pharma companies save on disposal costs and hit sustainability targets
New pallet improves cost and operational efficiency while reducing environmental impact; includes real-time visibility with cloud connectivity Key features include: * Made of fully reusable components and recyclable PCM (phase change material) refrigerants * New integrated real-time tracking...
Menarini Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Efficacy, Safety and Tolerability of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
-- Achieved primary endpoint of LS mean reduction in LDL-C on top of maximally tolerated lipid modifying therapies at week 12 with statistically significant reduction (p<0.0001), which was sustained at week 52 (p<0.0001) -- -- Obicetrapib lowered LDL-C by 36.3% at week 12 and by 41.5% at week 52,...
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™
The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland, July 29, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, today announced that...
Everise and Sanas Exclusively Partner to Transform Customer Experience With Real-Time AI Speech Understanding Technology
Partnership is exclusive within the healthcare BPO industry PLANTATION, Fla., July 29, 2024 /PRNewswire/ -- Everise, a leader in transforming customer service for global healthcare companies, today announced its exclusive partnership with Sanas, a global leader in real-time speech and accent con...
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00